The registration for this event has passed. Check back soon for content you missed, post-event updates, as well as recommendations for future events you may be interested in.
Details
The Australia New Zealand Gynaecological Oncology Group’s (ANZGOG) Annual Scientific Meeting will be held from the 23rd - 26th March 2022 and will proceed as a “hybrid” event with face-to-face and virtual content delivery. “Pathways to precision care” is the theme for 2022. ANZGOG will explore the pathways from translational research into to clinical trials; review how molecular profiles and genetics are shaping the management of ovarian and endometrial cancer. Attend the Illumina satellite symposium to learn more about Homologous Recombination Deficiency (HRD); its benefits, its accuracy and comprehensiveness, with a particular focus on ovarian cancer.
Illumina Satellite Symposium
Assessment of HR deficiency in ovarian cancer to increase PARP inhibitor targets beyond BRCA1/2.
Dr. Cristina Mapagu
Staff Specialist Medical Oncologist,
Illawarra Shoalhaven Local Health District, Australia
INOVATe Clinical Research Fellow,
Westmead Institute of Medical Research,
University of Sydney, Australia
Next Level Comprehensive Genomic Profiling with Gold-Standard Homologous Recombination Deficiency (HRD) Insights.
Joel Geoghegan
Manager, Sales Specialist (Oncology),
Illumina Asia Pacific Japan
Date:
Tuesday 22nd March 2022
Time:
3:30pm - 5:00pm
Where:
Crown Promenade Melbourne,
Level 1, Meeting Room 1
- Date & Time
- 23 Mar. 2022 – 26 Mar. 2022
- Location
- Hybrid - Online or In-person at the Crown Promenade Melbourne Hotel, Australia
- Australia
- Topic
- Oncology, Cancer research